Use for the diabetes treatment of compounds or salts thereof, having the following general formula (I): A-(B).sub.b0--(C).sub.c0--NO.sub.2 wherein A contains the radical of a drug having an antiinflammatory or analgesic activity, B is a bivalent linking group wherein the precursor must meet the tests described in the application, C is a a bivalent linking group as defined in the invention.